Skip to the page

Data / Drug companies / Aurobindo Pharma Limited

Aurobindo Pharma Limited: 738 products in the FDA NDC directory, labeler code 59651

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Aurobindo Pharma Limited (labeler code 59651) lists 738 products in the FDA National Drug Code Directory, covering 190 finished drugs by generic name. By type: 466 prescription drugs, 138 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 23, 2026.

The request: Watch Aurobindo Pharma Limited (FDA labeler code 59651): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
59651
Products in commercial distribution
738
Packages
1,163
Finished drugs by generic name
190
Prescription products
466
Over the counter products
0
Controlled substance products
Schedule IV 19, Schedule V 4
Flagged as original packager
423 of 423 products that carry the flag
Started marketing in the last 12 months
64
Products with a marketing end date set
3
Earliest marketing start
December 11, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)46563%
Drugs for further processing13818.7%
Bulk ingredients12717.2%
Bulk ingredients for compounding70.9%
New drug applications (NDA)10.1%

Products by type

TypeProductsShare
Prescription drugs46663.1%
Drugs for further processing13818.7%
Bulk ingredients13418.2%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Bupropion hydrochloride767
Metformin hydrochloride779
Propafenone hydrochloride615
Lenalidomide619
Prednisone649
Dasatinib618
Haloperidol632
Esomeprazole magnesium677
Fluoxetine642
Ciprofloxacin hydrochloride636
Deferasirox621
Isotretinoin616
Doxepin hydrochloride545
Clozapine513
Cephalexin536
Levothyroxine sodium544
Fenofibrate556
Amitriptyline hydrochloride535
Memantine hydrochloride536
Chlorpromazine hydrochloride527
Buspirone hydrochloride550
Potassium chloride584
Eslicarbazepine acetate410
Deflazacort411
Fluphenazine hydrochloride429
Ezetimibe and simvastatin48
Nebivolol421
Everolimus415
Pomalidomide412
Sunitinib malate49
Dapagliflozin and metformin hydrochloride410
Cimetidine419
Atorvastatin calcium459
Doxazosin mesylate412
Aripiprazole349
Clonidine hydrochloride345
Pirfenidone326
Droxidopa315
Zonisamide322
Nadolol317
Mycophenolate mofetil337
Clonazepam336
Oxcarbazepine346
Meclizine310
Dabigatran etexilate317
Midodrine hydrochloride334
Duloxetine hydrochloride318
Minocycline hydrochloride329
Ibuprofen3190
Varenicline311
Digoxin333
Rufinamide312
Nitrofurantoin (macrocrystals)32
Omeprazole3106
Nifedipine338
Chlorzoxazone321
Tizanidine hydrochloride325
Tofacitinib323
Diazepam351
Metronidazole368
Sotalol hydrochloride325
Furosemide363
Acyclovir370
Dofetilide312
Emtricitabine and tenofovir disoproxil fumarate328
Prazosin hydrochloride335
Clomipramine hydrochloride317
Spironolactone345
Erlotinib35
Isosorbide mononitrate325
Niacin313
Hydrocortisone3171
Hydroxyzine hydrochloride351
Glipizide339
Cyclosporine324
Naproxen358
Carbidopa and levodopa341
Nitroglycerin340
Bisoprolol fumarate and hydrochlorothiazide312
Azithromycin241
Darunavir214
Silodosin215
Dapagliflozin226
Flucytosine210
Dicloxacillin sodium27
Tretinoin228
Acetazolamide237
Teriflunomide217
Progesterone239
Fenofibric acid27
Tamoxifen citrate29
Methocarbamol267
Leflunomide219
Topiramate256
Prochlorperazine maleate231
Diclofenac sodium2109
Capecitabine219
Vigabatrin218
Etodolac231
Metoprolol tartrate246

Dosage forms

Dosage formProductsShare
Tablet18024.4%
Tablet, film coated13518.3%
Powder13318%
Capsule10614.4%
Tablet, extended release354.7%
Capsule, delayed release233.1%
Tablet, film coated, extended release182.4%
Solution131.8%
Capsule, liquid filled111.5%
Powder, for suspension101.4%
Tablet, delayed release91.2%
Tablet, orally disintegrating81.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Aztreoanm59651-859PowderBulk ingredientsOctober 23, 2026
Azilsartan kamedoxomil59651-498PowderBulk ingredientsOctober 23, 2026
Oxcarbazepine59651-787Tablet, film coated, extended releaseGeneric drugs (ANDA)October 16, 2026
Oxcarbazepine59651-786Tablet, film coated, extended releaseGeneric drugs (ANDA)October 16, 2026
Oxcarbazepine59651-785Tablet, film coated, extended releaseGeneric drugs (ANDA)October 16, 2026
Metronidazole Vaginal Gel59651-703GelGeneric drugs (ANDA)September 25, 2026
Cyclosporine59651-929Capsule, liquid filledGeneric drugs (ANDA)September 17, 2026
Cyclosporine59651-928Capsule, liquid filledGeneric drugs (ANDA)September 17, 2026
Cyclosporine59651-927Capsule, liquid filledGeneric drugs (ANDA)September 17, 2026
Amoxicillin59651-099PowderBulk ingredientsAugust 14, 2026
Brivaracetam59651-995SolutionGeneric drugs (ANDA)August 10, 2026
Vancomycin hydrochloride59651-670KitGeneric drugs (ANDA)August 7, 2026
Vancomycin hydrochloride59651-669KitGeneric drugs (ANDA)August 7, 2026
Eslicarbazepine acetate59651-536TabletGeneric drugs (ANDA)August 5, 2026
Eslicarbazepine acetate59651-535TabletGeneric drugs (ANDA)August 5, 2026
Eslicarbazepine acetate59651-534TabletGeneric drugs (ANDA)August 5, 2026
Eslicarbazepine acetate59651-533TabletGeneric drugs (ANDA)August 5, 2026
Adapalene and benzoyl peroxide59651-604GelGeneric drugs (ANDA)July 22, 2026
Bupropion hydrochloride59651-512Tablet, film coated, extended releaseGeneric drugs (ANDA)July 21, 2026
Bupropion hydrochloride59651-511Tablet, film coated, extended releaseGeneric drugs (ANDA)July 21, 2026
Etodolac59651-462Tablet, film coatedDrugs for further processingJuly 15, 2026
Etodolac59651-462Tablet, film coatedGeneric drugs (ANDA)July 15, 2026
Etodolac59651-461Tablet, film coatedGeneric drugs (ANDA)July 15, 2026
Etodolac59651-461Tablet, film coatedDrugs for further processingJuly 15, 2026
Icosapent ethyl59651-812CapsuleGeneric drugs (ANDA)June 24, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.